Market Overview:
The global venous thromboembolism treatment market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The market growth is attributed to the increasing incidence of venous thromboembolism, rising geriatric population, and technological advancements in the field of diagnosis and treatment. However, the high cost of treatment may restrain the market growth during the forecast period. Based on type, deep vein thrombosis (DVT) accounted for a larger share in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to factors such as increasing incidence of DVT due to sedentary lifestyle and changing dietary habits, growing awareness about early diagnosis and prevention measures for DVT through various campaigns undertaken by healthcare organizations worldwide, and technological advancements in diagnostic techniques for DVT such as ultrasound-based methods that are less invasive than traditional methods such as angiography. Based on application, hospitals held a larger share in 2017 owing to increased number of hospital admissions due to various medical conditions including venous thromboembolism.
Product Definition:
Venous thromboembolism (VTE) is a blood clot that forms in a vein, usually in the leg. If the clot breaks free and travels to the lungs, it can cause a pulmonary embolism (PE), which can be fatal. VTE is treated with anticoagulants (blood thinners), which help break up clots and keep them from forming again.
Deep Venous Thrombosis:
Deep venous thrombosis (DVT) is a blood clot that forms in the deep veins of the legs, which may eventually break off and travel to the lungs, causing pulmonary embolism. DVT is more common among people who have recently undergone surgery or been on long-term sick leave; pregnant women; and people with weak immune systems.
Pulmonary Embolism:
Pulmonary Embolism (PE) is a condition in which blood clots form in the lungs and may cause serious damage to the organ. It is also known as pulmonary thromboembolism (PTE). Pulmonary embolism usually occurs due to deep vein thrombosis or pulmonary hypertension.
Application Insights:
Based on application, the market is segmented into hospitals, clinics and other medical facilities. Hospitals held the largest share of over 70% in 2017. The primary factor contributing to this large share is that hospitals are considered to be a higher grade of care than clinics or medical facilities due to a higher level of expertise required in diagnosing and treating VTEs.
The others application segment includes home healthcare services and private physicians offices/clinics. Venous thromboembolism (VTE) treatment at private physicians offices/clinics was estimated to be around USD 25 million in 2015 while that at home was supposed to be around USD 12 million in the same year according these estimates venous thromboembolism affects mostly older people who have other diseases or conditions which increase their risk for VTEs by 30%.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. This can be attributed to the high incidence rate of venous thromboembolism, rising adoption of cost-effective and advanced technologies, well-established healthcare infrastructure, and favorable reimbursement policies & regulatory reforms. In addition, higher patient awareness levels coupled with a higher disposable income are some other factors responsible for its large share.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to improving healthcare facilities due to increasing investments by public as well as private players along with government support for improvement in medical services at a relatively low cost. Moreover, an increase in air travel across Asia Pacific has led to an increase in cases of venous thromboembolism (VTE). Thus these factors are expected to drive this regional market during the forecast period.
Growth Factors:
- Increasing incidence of venous thromboembolism (VTE) due to changing lifestyle and increasing prevalence of risk factors such as obesity, smoking, and advancing age.
- Growing demand for prophylactic anticoagulants to prevent VTE in high-risk patients.
- Increasing use of novel oral anticoagulants (NOACs) for the treatment of VTE owing to their better safety and efficacy profile as compared to traditional warfarin therapy.
- Rising number of surgical procedures resulting in an increase in the incidence of postoperative VTEs.
- Growing awareness about the symptoms and risk factors associated with VTE among patients and healthcare professionals
Scope Of The Report
Report Attributes
Report Details
Report Title
Venous Thromboembolism Treatment Market Research Report
By Type
Deep Venous Thrombosis, Pulmonary Embolism
By Application
Hospitals, Clinics, Others
By Companies
Medtronic, Boston Scientific, Stryker, AngioDynamics, Cook Medical, Cardinal Health, DJO Global, Philips Holding, ArjoHuntleigh AB, Argon Medical Devices, DaeSung Maref, ALN Implants Chirurgicaux, Lifetech Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
206
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Venous Thromboembolism Treatment Market Report Segments:
The global Venous Thromboembolism Treatment market is segmented on the basis of:
Types
Deep Venous Thrombosis, Pulmonary Embolism
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Boston Scientific
- Stryker
- AngioDynamics
- Cook Medical
- Cardinal Health
- DJO Global
- Philips Holding
- ArjoHuntleigh AB
- Argon Medical Devices
- DaeSung Maref
- ALN Implants Chirurgicaux
- Lifetech Scientific
Highlights of The Venous Thromboembolism Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Deep Venous Thrombosis
- Pulmonary Embolism
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Venous Thromboembolism Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Venous thromboembolism (VTE) is a condition in which blood clots form in the veins. These clots can travel to the lungs and cause serious problems, including death. Treatment for VTE includes anticoagulation (blood thinning) medications and, if necessary, surgery to remove the clot.
Some of the major players in the venous thromboembolism treatment market are Medtronic, Boston Scientific, Stryker, AngioDynamics, Cook Medical, Cardinal Health, DJO Global, Philips Holding, ArjoHuntleigh AB, Argon Medical Devices, DaeSung Maref, ALN Implants Chirurgicaux, Lifetech Scientific.
The venous thromboembolism treatment market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Venous Thromboembolism Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Venous Thromboembolism Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Venous Thromboembolism Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Venous Thromboembolism Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Venous Thromboembolism Treatment Market Size & Forecast, 2018-2028
4.5.1 Venous Thromboembolism Treatment Market Size and Y-o-Y Growth
4.5.2 Venous Thromboembolism Treatment Market Absolute $ Opportunity
Chapter 5 Global Venous Thromboembolism Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Venous Thromboembolism Treatment Market Size Forecast by Type
5.2.1 Deep Venous Thrombosis
5.2.2 Pulmonary Embolism
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Venous Thromboembolism Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Venous Thromboembolism Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Venous Thromboembolism Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Venous Thromboembolism Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Venous Thromboembolism Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Venous Thromboembolism Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Venous Thromboembolism Treatment Market Size Forecast by Type
9.6.1 Deep Venous Thrombosis
9.6.2 Pulmonary Embolism
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Venous Thromboembolism Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Venous Thromboembolism Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Venous Thromboembolism Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Venous Thromboembolism Treatment Market Size Forecast by Type
10.6.1 Deep Venous Thrombosis
10.6.2 Pulmonary Embolism
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Venous Thromboembolism Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Venous Thromboembolism Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Venous Thromboembolism Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Venous Thromboembolism Treatment Market Size Forecast by Type
11.6.1 Deep Venous Thrombosis
11.6.2 Pulmonary Embolism
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Venous Thromboembolism Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Venous Thromboembolism Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Venous Thromboembolism Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Venous Thromboembolism Treatment Market Size Forecast by Type
12.6.1 Deep Venous Thrombosis
12.6.2 Pulmonary Embolism
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Venous Thromboembolism Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Venous Thromboembolism Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Venous Thromboembolism Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Venous Thromboembolism Treatment Market Size Forecast by Type
13.6.1 Deep Venous Thrombosis
13.6.2 Pulmonary Embolism
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Venous Thromboembolism Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Venous Thromboembolism Treatment Market: Competitive Dashboard
14.2 Global Venous Thromboembolism Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Boston Scientific
14.3.3 Stryker
14.3.4 AngioDynamics
14.3.5 Cook Medical
14.3.6 Cardinal Health
14.3.7 DJO Global
14.3.8 Philips Holding
14.3.9 ArjoHuntleigh AB
14.3.10 Argon Medical Devices
14.3.11 DaeSung Maref
14.3.12 ALN Implants Chirurgicaux
14.3.13 Lifetech Scientific
